Antıbody to Tocılızumab ELISA

Enzyme immunoassay for the quantitative and qualitative determination of free antibodies to Tocilizumab (Actemra®) in serum and plasma.

The solid phase (MTP) is coated by the drug Tocilizumab. Due to the assay design this test measures the free antibodies which are not bound to Tocilizumab. Results could be expressed in both qualitative and quantitative manner (nanogram per mililiter-ng/mL).

Reference: IG-BB108

Barcode: 8682754930240

Legal Status: CE-Mark

Intended Use: This kit has been developed for the detection of anti-drug antibodies in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.

Assay Design:

Related Documents

Quality Control Certificates

Actemra® is a trademark of Chugai Seiyaku Kabushiki Kaisha Corp.

Required Volume (µL) 50
Incubation Time (min) 135
Sample Serum or Plasma
Package Size 96 Tests
Results in Qualitative & Quantitative (ng/mL)
Shelf Life (years) 2